Publications

Detailed Information

Role of GnRH-GnRH receptor signaling at the maternal-fetal interface

DC Field Value Language
dc.contributor.authorLee, Hee Joong-
dc.contributor.authorSnegovskikh, Victoria V.-
dc.contributor.authorPark, Joong Shin-
dc.contributor.authorFoyouzi, Nastaran-
dc.contributor.authorHodgson, Eric J.-
dc.contributor.authorNorwitz, Errol R.-
dc.contributor.authorGuller, Seth-
dc.contributor.authorHan, Ku Taek-
dc.date.accessioned2012-06-04T05:59:36Z-
dc.date.available2012-06-04T05:59:36Z-
dc.date.issued2010-12-
dc.identifier.citationFERTILITY AND STERILITY; Vol.94 7; 2680-2687ko_KR
dc.identifier.issn0015-0282-
dc.identifier.urihttps://hdl.handle.net/10371/76786-
dc.description.abstractObjective: To investigate the expression and function of GnRH and GnRH receptor (GnRHR) subtypes at the maternal-fetal interface. Design: In vitro experiments using freshly isolated human trophoblast cells, decidual stromal cells (DSCs), and immortalized cell lines. Setting: University teaching hospital. Patient(S): Placenta-fetal membranes from term deliveries. Intervention(s): Human trophoblast and DSCs were isolated, purified, and cultured. Main Outcome Measure(s): Expression of GnRH-I, GnRH-II, and GnRHR-I mRNA and protein in human trophoblast cell lines and tissues were evaluated by reverse-transcription polymerase chain reaction and Western blot. The effect of GnRH-I and -II on the production of select cytokines (hCG, interleukin [IL] 8, IL-6, matrix metalloproteinase 3, monocyte chemoattractant protein 1, vascular endothelial growth factor, soluble Fms-like tyrosine kinase 1, urokinase-type plasminogen activator, and plasminogen activator inhibitor 1) were measured by ELISA and normalized for protein content. Result(s): GnRH-I, GnRH-II, and GnRHR-I mRNA and protein were identified in trophoblasts and decidua. GnRH-I and -II stimulated hCG production by trophoblast and trophoblast-derived cell lines in a dose-dependent fashion (e. g., 2.8-fold, from 2.5 +/- 0.5 to 7.0 +/- 0.4 ng/mg protein per 24 h, for 1,000 nmol/L GnRH-I and 2.4-fold, from 2.5 +/- 0.5 to 6.1 +/- 0.6 ng/mg protein per 24 h, for 1,000 nmol/L GnRH-II) without affecting the production of other cytokines. Conclusion(s): Trophoblasts and decidua express GnRH-I, GnRH-II, and GnRHR-I mRNA and protein. GnRH-I and -II selectively stimulate hCG production by trophoblast cells without altering the production of select cytokines by trophoblasts or decidua. The role of GnRH-GnRHR signaling at the maternal-fetal interface therefore appears to be limited to the regulation of trophoblast hCG production. (Fertil Steril (R) 2010;94:2680-7. (C) 2010 by American Society for Reproductive Medicine.)ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE INCko_KR
dc.subjectGnRHko_KR
dc.subjectplacentako_KR
dc.subjectdeciduako_KR
dc.subjecthCGko_KR
dc.subjectGnRH receptorko_KR
dc.subjectcytokinesko_KR
dc.subjectpregnancyko_KR
dc.subjecthumanko_KR
dc.titleRole of GnRH-GnRH receptor signaling at the maternal-fetal interfaceko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이희중-
dc.contributor.AlternativeAuthor박중신-
dc.contributor.AlternativeAuthor한구택-
dc.identifier.doi10.1016/j.fertnstert.2010.03.016-
dc.citation.journaltitleFERTILITY AND STERILITY-
dc.description.citedreferenceSnegovskikh VV, 2009, REPROD SCI, V16, P767, DOI 10.1177/1933719109336623-
dc.description.citedreferenceFest S, 2008, AM J REPROD IMMUNOL, V59, P75, DOI 10.1111/j.1600-0897.2007.00557.x-
dc.description.citedreferenceMeade ES, 2007, PLACENTA, V28, P1012, DOI 10.1016/j.placenta.2607.04.005-
dc.description.citedreferenceLu ZL, 2007, J BIOL CHEM, V282, P17921, DOI 10.1074/jbc.M610413200-
dc.description.citedreferenceLockwood CJ, 2007, AM J PATHOL, V170, P1398, DOI 10.2353/ajpath.2007.060465-
dc.description.citedreferenceNORWITZ ER, 2007, AM J OBSTET GYNECOL, V196, pNI523-
dc.description.citedreferenceElustondo PA, 2006, BIOL REPROD, V74, P959, DOI 10.1095/biolreprod.105.050419-
dc.description.citedreferenceWang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508-
dc.description.citedreferenceLu ZL, 2005, J BIOL CHEM, V280, P29796, DOI 10.1074/jbc.M413520200-
dc.description.citedreferenceLockwood CJ, 2005, J CLIN ENDOCR METAB, V90, P4710, DOI 10.1210/jc.2004-2528-
dc.description.citedreferencePawson AJ, 2005, ENDOCRINOLOGY, V146, P2639, DOI 10.1210/en.2005-0133-
dc.description.citedreferenceMackenzie AP, 2004, AM J OBSTET GYNECOL, V191, P1996, DOI 10.1016/j.ajog.2004.08.003-
dc.description.citedreferenceRama S, 2004, MOL CELL ENDOCRINOL, V218, P79, DOI 10.1016/j.mce.2003.12.016-
dc.description.citedreferenceKoopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305-
dc.description.citedreferenceChou CS, 2003, J CLIN ENDOCR METAB, V88, P4781, DOI 10.1210/jc.2003-030659-
dc.description.citedreferenceChou CS, 2003, J CLIN ENDOCR METAB, V88, P3806, DOI 10.1210/jc.2002-021955-
dc.description.citedreferenceMorgan K, 2003, ENDOCRINOLOGY, V144, P423, DOI 10.1210/en.2002-220622-
dc.description.citedreferenceChou CS, 2003, J CLIN ENDOCR METAB, V88, P680, DOI 10.1210/jc.2002.021277-
dc.description.citedreferenceMillar RP, 2003, TRENDS ENDOCRIN MET, V14, P35-
dc.description.citedreferenceChou CS, 2002, J CLIN ENDOCR METAB, V87, P5594, DOI 10.1210/jc.2002-020883-
dc.description.citedreferencevan Biljon W, 2002, BIOL REPROD, V67, P1741, DOI 10.1095/bioreprod.101.002808-
dc.description.citedreferencePfleger KDG, 2002, MOL ENDOCRINOL, V16, P2155, DOI 10.1210/me.2002-0159-
dc.description.citedreferenceGrundker C, 2002, J CLIN ENDOCR METAB, V87, P1427-
dc.description.citedreferenceNeill JD, 2002, ENDOCRINOLOGY, V143, P737-
dc.description.citedreferenceROSEN T, 2002, J MATERN-FETAL NEO M, V11, P11-
dc.description.citedreferenceFaurholm B, 2001, GENOMICS, V78, P15-
dc.description.citedreferenceLala PK, 2001, PLACENTA, V22, P889-
dc.description.citedreferenceMillar R, 2001, P NATL ACAD SCI USA, V98, P9636-
dc.description.citedreferenceSiler-Khodr TM, 2001, J SOC GYNECOL INVEST, V8, P233-
dc.description.citedreferenceNeill JD, 2001, BIOCHEM BIOPH RES CO, V282, P1012-
dc.description.citedreferenceSiler-Khodr TM, 2001, J CLIN ENDOCR METAB, V86, P804-
dc.description.citedreferenceWang L, 2001, P NATL ACAD SCI USA, V98, P361-
dc.description.citedreferenceIslami D, 2001, MOL HUM REPROD, V7, P3-
dc.description.citedreferenceNathwani PS, 2000, ENDOCRINOLOGY, V141, P1754-
dc.description.citedreferenceDi Simone N, 2000, ARTHRITIS RHEUM, V43, P140-
dc.description.citedreferenceMillar R, 1999, J ENDOCRINOL, V162, P117-
dc.description.citedreferenceRaga F, 1999, J CLIN ENDOCR METAB, V84, P636-
dc.description.citedreferenceWhite RB, 1998, P NATL ACAD SCI USA, V95, P305-
dc.description.citedreferenceEmons G, 1997, TRENDS ENDOCRIN MET, V8, P355-
dc.description.citedreferenceKAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145-
dc.description.citedreferenceGULLER S, 1993, J STEROID BIOCHEM, V46, P1-
dc.description.citedreferenceGRAHAMCH, 1993, EXP CELL RES, V206, P204-
dc.description.citedreferenceBRAMLEY TA, 1992, PLACENTA, V13, P555-
dc.description.citedreferenceBELISLE S, 1989, J CLIN ENDOCR METAB, V69, P117-
dc.description.citedreferenceKIM SJ, 1987, PLACENTA, V8, P257-
dc.description.citedreferenceKLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567-
dc.description.citedreferenceKAIHO T, 1984, NIPPON SANKA FUJINHA, V36, P1801-
dc.description.citedreferencePOPKIN R, 1983, BIOCHEM BIOPH RES CO, V114, P750-
dc.description.citedreferenceMIYAKE A, 1982, OBSTET GYNECOL, V60, P444-
dc.description.citedreferenceBUTZOW R, 1982, INT J CANCER, V15, P9-
dc.description.citedreferenceCURRIE AJ, 1981, BIOCHEM BIOPH RES CO, V99, P332-
dc.description.citedreferenceKHODR GS, 1980, SCIENCE, V207, P315-
dc.description.citedreferenceSILERKHODR TM, 1978, AM J OBSTET GYNECOL, V130, P216-
dc.description.citedreferenceJAFFE RB, 1969, J CLIN ENDOCR METAB, V29, P1281-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share